AstraZeneca seeking R&D potential in Korea

Published: 2011-09-21 06:56:00

Updated: 2011-09-21 06:56:00

AstraZeneca (AZ), the world's sixth-largest pharmaceutical company, plans to select six Korean research teams to participate in the sixth Virtual Research Institute (VRI) from September 19 to October 19.

The selected VRI team will receive about $35,000 research fund to study a variety of new d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK